April 15, 2021 02:01 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bengal Elections: Video clip on Sitalkuchi incident goes viral | Karnataka reports 11,265 Covid cases, highest one-day spike this year | No decision to cut short Kumbh Mela: Officials | Delhi reports over 17000 fresh Covid cases setting a new single-day record | Rajasthan announces 12-hr daily Covid curfew from 6 pm to 6 am in all cities

India approves Russia’s Sputnik V Covid vaccine: Reports

New Delhi/UNI: A Subject Expert Committee (SEC) of central government on Monday gave its nod for the emergency use authorization of the Russia's COVID-19 vaccine SPUTNIK V, sources said.

Brazil denies permission to import Bharat Biotech developed Covaxin

New Delhi/IBNS:  Brazil's health regulator has denied permission to import Covaxin, the coronavirus vaccine developed by India's indigenous firm Bharat Biotech.

Paraguay receives 100,000 doses of India's Covaxin: Health Ministry

Buenos Aires/UNI: Paraguay on Monday received the shipment of 100,000 doses of India's first domestically-produced COVID-19 vaccine Covaxin, the country's Health Ministry said.

Nepal approves emergency use of India's COVID-19 vaccine COVAXIN

Kathmandu: Nepal has approved India's COVAXIN COVID-19 vaccine for emergency use, media reports said.

Covaxin taken off clinical trial mode, no consent forms required

New Delhi/IBNS: Pharmaceutical company Bharat Biotech's indigenous Coronavirus vaccine-Covaxin-has been taken off the clinical trial mode, which means beneficiaries will not have to sign consent forms before taking the drug.

COVAXIN is 81 pct effective: Bharat Biotech 

Hyderabad: Bharat Biotech, a global leader in vaccine innovation,developing vaccines for infectious diseases, today announced the first interim analysis of itsBBV152 (COVAXIN) where it showed it was 81 percent effective. 

India begins second phase of COVID vaccination today: Check out the procedures

New Delhi: In its fight against COVID-19, India started its second phase of vaccination from Monday.

Delhi resident doctors prefer Covishield over indigenous Covaxin in Covid-19 vaccination drive

New Delhi/IBNS: Within hours after Prime Minister Narendra Modi launched the Covid-19 vaccination drive, the resident doctors of Delhi on Saturday preferred to be inoculated with Oxford vaccine, named Covishield in India, over the indigenous Covaxin.

Covid-19 vaccination drive starts in Assam

Guwahati/UNI: The Covid-19 vaccination drive started in Assam on Saturday along with other parts of the country.

PM Modi launches world's biggest Covid-19 vaccination drive in India

New Delhi/IBNS: Prime Minister Narendra Modi on Saturday launched the world's biggest Covid-19 vaccination drive in India, which is one of the worst Novel Coronavirus-hit countries.

PM Modi to launch pan India Covid-19 vaccination drive at 10:30 AM on Saturday

New Delhi/IBNS: Prime Minister Narendra Modi will launch the pan India rollout of COVID-19 vaccination drive on Jan 16 at 10:30 AM via video conferencing. 

PM Modi likely to inaugurate Coronavirus vaccination drive virtually on Jan 16

New Delhi/IBNS: Prime Minister Narendra Modi is likely to inaugurate the coronavirus vaccination drive virtually on January 16, said media reports.

Congress MP Manish Tewari questions roll out of Covaxin

New Delhi/IBNS: Congress leader Manish Tewari has raised questions over unavailability of options in choosing the Coronavirus vaccine, according to media reports.

Covid-19: Bharat Biotech rolls out India's indigenous vaccine Covaxin

Hyderabad/IBNS: A day after the Serum Institute of India (SII) rolled out its vaccine against Covid-19, the first batch of India's indigenous remedy Covaxin, made by Bharat Biotech, left Hyderabad for 11 cities on Wednesday morning, media reports said.

Covid vaccine recipients don't get to choose between two options for now: Centre

New Delhi/IBNS: The Indian government on Tuesday said that no recipient of Covid-19 vaccine gets to choose from the two candidates available in the country for emergency use.